ChemoStart 10th Edition

About

Insud Pharma’s philanthropic ChemoStart programme offers selected health and biomedicine projects tailored mentoring, expert access and investor connections, with applications for its 10th edition due 20 November 2026.

Benefits

• 🧭Personalized mentorship
  Selected projects receive tailored mentoring and coaching to define a project roadmap and identify suitable mentors.
• 🤝Expert and network access
  Selected projects can access Insud Pharma's internal resources, industry experts and contact network for support and pilot tests.
• 💼Investor access
  Projects may be presented to healthcare investors, and Insud Pharma may act as an individual investor if the project aligns with its strategic interests.
• 🧪Specialized guidance
  Support can cover regulatory, legal, patents, clinical validation and investor relations.
• ⏱️Up to six months of support
  The accompaniment can extend for a maximum of six months, depending on the project's needs.
• 💸No cost or equity
  The program is described as free of charge and does not require equity participation.

Eligibility Criteria

• Open to independent projects, whether individual or team-based
• Open to legally established companies and organizations
• Aimed at entrepreneurs, researchers, start-ups, multidisciplinary teams and organizations developing solutions for human health
• No specific nationality, residence or incorporation-country requirement is stated in official program materials

Participation Commitments

• Applications must be submitted through the online form by 20 November 2026
• The application form must be completed in full with the necessary information
• Selected projects may present their proposals to a panel of experts at Pitch Day, held in January of the following year either virtually or at Insud Pharma's headquarters
• The personalised support programme can run for up to six months
• No fee is charged and no equity is required, according to public descriptions of the programme

Target Region

Geographic eligibility is not publicly stated and should be confirmed before applying.

Target Sector

Healthcare & Life Sciences